MedPath

PREPARE- Prehabilitation for Patients Awaiting Liver Transplantation: Feasibility and Acceptability Testing.

Not Applicable
Recruiting
Conditions
Liver Transplant
Interventions
Behavioral: Prehabilitation
Registration Number
NCT06036225
Lead Sponsor
Belfast Health and Social Care Trust
Brief Summary

This is a study developing a prehabilitation intervention and then testing the acceptability and feasibility of the intervention.

Start date Aug 2022 for Focus groups and Feb 2023 Co-design workshops and feasibility study date pending

Detailed Description

This study is using focus groups and experience based co-design workshops to co-design a remote multicomponent prehabilitation intervention for patients awaiting liver transplantation.

Once the intervention is developed it will then be tested for acceptability and feasibility with the liver transplantation cohort in Belfast Northern Ireland.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • on the transplant waiting list
  • grade 3 below for encephalopathy
Exclusion Criteria
  • grade 4 above encephalopathy
  • Known adverse reaction to exercise
  • New stroke
  • lacks capacity to consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Receiving the prehabilitation interventionPrehabilitationAll participants will receive the prehabilitation intervention.
Primary Outcome Measures
NameTimeMethod
Adherence6 months

This will be recorded using percentage and will be defined by

1. Number of participants who attended 1:1 sessions.

2. Number of participants who attended the group exercise classes using a class log.

3. Number of participants who attend the online monthly peer support sessions while active on the liver transplantation waiting list.

4. Number of participants who accessed the website/web app.

5. Which sections of the website/web app are utilised and the number of participants who access each section.

6. Number of participants who wear the activity tracker and report weekly step count.

Min score 0% Max Score 100% Higher values indicate a higher adherence rate.

Retention6 months

This will be recorded using percentage and will be defined by

1. Number of participants who completed the baseline assessment.

2. Number of participants who completed the 12-week iPRehab study.

3. Number of participants who completed the assessment 1 week post the iPRehab study.

4. Number of participants who completed the assessment 12 weeks post the iPRehab study.

5. Number of participants who drop out and the reasons

Min score 0% Max Score 100% Higher values indicate a higher retention rate.

Recruitment6 months

It will be presented in percentage form and will be defined by

1. Number of participants active on the list.

2. Number of participants eligible to participate.

3. Number of participants informed about the iPRehab study.

4. Number of participants who were interested in participating.

5. Number of participants recruited.

6. Number of participants interested but didn't recruit and reasons why.

7. Number of participants who own a computer/phone/tablet.

8. Number of participants who can use a computer/phone/tablet independently.

9. Number of participants who need support to use a device. Detail the support required.

Min score 0% Max Score 100% Higher values indicate a higher recruitment rate.

Acceptability6 months

This will be measured using an acceptability questionnaire.

Min score 0% Max Score 100% Higher values indicate a higher acceptability.

Secondary Outcome Measures
NameTimeMethod
Physical function6 months

6 minute walk test. This will be recorded in meters covered in the 6 minute duration of the test.

Min score 0 Max Score 1000

Higher values indicate better physical function.

Frailty6 months

The Liver frailty index. This index will determine the degree of frailty patients present while awaiting liver transplantation. This scale determines if the patients are frail, pre-frail or robust.

Min score 1 Max Score 7 Higher values indicate a higher degree of frailty.

Trial Locations

Locations (1)

Queen's University Belfast

🇬🇧

Belfast, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath